|
RFC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48650000086903E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.44630000385038E-08 |
| Normal-vs-Stage2 |
2.646300E-04 |
| Normal-vs-Stage3 |
2.217600E-04 |
| Normal-vs-Stage4 |
7.010900E-04 |
| Stage1-vs-Stage2 |
8.705000E-01 |
| Stage1-vs-Stage3 |
9.007600E-01 |
| Stage1-vs-Stage4 |
9.251600E-01 |
| Stage2-vs-Stage3 |
9.545800E-01 |
| Stage2-vs-Stage4 |
8.087600E-01 |
| Stage3-vs-Stage4 |
8.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.73129999623012E-08 |
| Normal-vs-AfricanAmerican |
5.33030000027246E-07 |
| Normal-vs-Asian |
2.999500E-04 |
| Caucasian-vs-AfricanAmerican |
6.785200E-01 |
| Caucasian-vs-Asian |
4.338200E-01 |
| AfricanAmerican-vs-Asian |
4.776000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.32650051737949E-10 |
| Normal-vs-Female |
4.422200E-03 |
| Male-vs-Female |
7.096700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.52710000000434E-05 |
| Normal-vs-Extreme_Weight |
8.05689959193501E-10 |
| Normal-vs-Obese |
9.382000E-04 |
| Normal-vs-Extreme_Obese |
1.622520E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.674800E-01 |
| Normal_Weight-vs-Obese |
3.123800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.912200E-01 |
| Extreme_Weight-vs-Obese |
2.393800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.879000E-01 |
| Obese-vs-Extreme_Obese |
2.668000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.537190E-03 |
| Normal-vs-Age(41-60Yrs) |
1.61910999999515E-05 |
| Normal-vs-Age(61-80Yrs) |
1.27199994981453E-09 |
| Normal-vs-Age(81-100Yrs) |
7.362800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.862600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.946200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.507000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.870100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.345400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.802600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.62720006544748E-10 |
| Normal-VS-Type2 PRCC |
6.154600E-04 |
| Normal-VS-KIRP CIMP |
8.592700E-04 |
| Normal-VS-Unclassified PRCC |
5.683600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.100200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.672000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.064820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.090000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.575200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.732200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58860000043504E-07 |
| Normal-vs-N1 |
1.995200E-03 |
| Normal-vs-N2 |
5.091700E-02 |
| N0-vs-N1 |
2.110000E-01 |
| N0-vs-N2 |
5.654600E-01 |
| N1-vs-N2 |
9.622000E-01 |
|
|
